O-RAN-ALLIANCE-E.V.
As of February 23, 2021, the O-RAN ALLIANCE welcomes DISH Network as a new member of its Board of Directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005553/en/
“Carriers around the world are recognizing the importance of building next-generation, programmable networks that are open, intelligent and flexible, making the work of the O-RAN ALLIANCE more critical than ever,” said Sidd Chenumolu, DISH vice president of technology development. “At DISH, we are in a unique position as we build a 5G network entirely upon O-RAN standards, and the work of this organization creates a unified roadmap as our partners join us in developing a disaggregated and open RAN. We look forward to playing a continued role in the success of the O-RAN ALLIANCE and the development of standards that enhance connectivity worldwide.”
O-RAN ALLIANCE’s Minimum Viable Plan (MVP) Towards Commercial O-RAN Solutions
O-RAN’s specification effort, open software development, as well as testing and integration, will focus on priorities set by its operator members. This approach will allow the O-RAN ecosystem players to prioritize the delivery of a minimum viable set of end-to-end O-RAN solutions applicable in commercial networks.
The first release of the MVP includes already published specifications and additional work items in the area of:
- Open fronthaul specifications provide fully specified control, user and synchronization interface, management plane interface between O-RU and O-DU, and relevant conformance and interoperability tests, enabling multi-vendor interoperability.
- Open transport defines the requirements of xhaul transport, proposes the best practices of deploying WDM and IP technologies in xhaul.
- Open hardware offers hardware reference designs for different modes of indoor picocell, outdoor microcell, outdoor Macrocell and open fronthaul gateway to accelerate the use of whitebox and facilitate RAN ecosystem diversity.
- Open stack provides a software reference design for O-CU/O-DU architecture, interfaces, internal modules, and APIs, to promote and guide the open source software development.
- Open cloud presents O-Cloud reference design with the fundamental synchronization requirements and real life deployment recommendations.
- Testing and integration sets the criteria and guidelines for the formation of Open Testing and Integration Centers (OTICs) , ensuring consistency and quality of the testing of O-RAN products and solutions.
Subsequent O-RAN releases will extend the MVP with additional features and functionalities based on continuing surveys and updates of operators’ deployment priorities.
28 New or Updated O-RAN Specifications Released since November 2020
On February 26, 2021, the O-RAN ALLIANCE published another 28 specification documents, including 10 new titles. For more details on the new specifications, please check this O-RAN blog post . To download O-RAN specifications, please proceed to www.o-ran.org/specifications .
O-RAN Open Summit Held on February 25, 2021 Available for Re-play
The O-RAN Open Summit on February 25, 2021 has gained attention with more than 2500 global visitors. The recording of Open Summit is available at the O-RAN website . The recording includes full content of the event, including five keynotes:
- Opening address - Alex Jinsung Choi , COO of O-RAN ALLIANCE and SVP Technology Strategy & Innovation of Deutsche Telekom
- Chairman address - Andre Fuetsch , Chairman of the O-RAN ALLIANCE and Chief Technology Officer of AT&T
- O-RAN Technical progress - Chih-Lin I , Co-Chair of O-RAN Technical Steering Committee and China Mobile Chief Scientist, Wireless Technologies, China Mobile Research Institute
- Testing and Integration Focus Group update - David Orloff , Co-chair of O-RAN Testing and Integration Focus Group, AT&T
- O-RAN Software Community update - Jack Murray , Co-Chair of OSC Technical Oversight Committee, AT&T
The event recording also includes the panel discussion on ‘Paths to O-RAN implementation ’ providing valuable insights on possible ways towards open RAN introduction in the public mobile networks. The panelists represent a great variety of players in the O-RAN ecosystem: AT&T, NTT DOCOMO, Orange, TIM, O-RAN ALLIANCE, Intel, Keysight, ONF, Nokia and Radisys.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 270 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005553/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press release
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancerFDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet need BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currentl
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom